BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 26615705)

  • 1. Antisecretory medication is associated with decreased Helicobacter pylori detection in gastric marginal zone lymphoma.
    Schaberg KB; Evans MF; Wilcox R; Lewis MR
    Ann Diagn Pathol; 2015 Dec; 19(6):397-402. PubMed ID: 26615705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: follow-up study of 48 cases.
    Begum S; Sano T; Endo H; Kawamata H; Urakami Y
    J Med Invest; 2000 Feb; 47(1-2):36-46. PubMed ID: 10740978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan.
    Nakamura S; Sugiyama T; Matsumoto T; Iijima K; Ono S; Tajika M; Tari A; Kitadai Y; Matsumoto H; Nagaya T; Kamoshida T; Watanabe N; Chiba T; Origasa H; Asaka M;
    Gut; 2012 Apr; 61(4):507-13. PubMed ID: 21890816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
    Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S
    Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased plasmacytic differentiation in gastric mucosa-associated lymphoid tissue lymphomas: Helicobacter pylori eradication response and IgG4+ plasma cell association.
    Park S; Ahn S; Hong M; Ko YH
    Hum Pathol; 2017 Jan; 59():113-119. PubMed ID: 27697589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term clinical outcome of helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma is comparable to that of h. pylori-positive lymphoma.
    Chung SJ; Kim JS; Kim H; Kim SG; Kim CW; Jung HC; Song IS
    J Clin Gastroenterol; 2009 Apr; 43(4):312-7. PubMed ID: 18936712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of Helicobacter pylori-positive and Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma and their influence on clinical outcome.
    Choi YJ; Kim N; Paik JH; Kim JM; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Jung HC
    Helicobacter; 2013 Jun; 18(3):197-205. PubMed ID: 23305046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph node involvement rate in low-grade gastric mucosa-associated lymphoid tissue lymphoma--too high to be neglected.
    Chang DK; Chin YJ; Kim JS; Jung HC; Kim CW; Song IS; Kim CY
    Hepatogastroenterology; 1999; 46(28):2694-700. PubMed ID: 10522067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential response to H. pylori eradication therapy of co-existing diffuse large B-cell lymphoma and MALT lymphoma of stomach-significance of tumour cell clonality and BCL10 expression.
    Kuo SH; Chen LT; Wu MS; Kuo KT; Yeh KH; Doong SL; Yeh PY; Hsu HC; Tzeng YS; Lin CW; Lin JT; Cheng AL
    J Pathol; 2007 Feb; 211(3):296-304. PubMed ID: 17167822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up.
    Montalban C; Santon A; Boixeda D; Redondo C; Alvarez I; Calleja JL; de Argila CM; Bellas C
    Haematologica; 2001 Jun; 86(6):609-17. PubMed ID: 11418369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic impact of Helicobacter pylori infection and eradication therapy in gastric mucosa-associated lymphoid tissue lymphoma].
    Park SH; Chi HS; Park SJ; Jang S; Park CJ; Huh JR
    Korean J Lab Med; 2010 Dec; 30(6):547-53. PubMed ID: 21157137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori and lymphoid follicles in primary gastric MALT-lymphoma in Mexico.
    Herrera-Goepfert R; Garcia-Marcano R; Zeichner-Gancz I
    Rev Invest Clin; 1996; 48(4):261-5. PubMed ID: 8916447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosa-associated lymphoid tissue (MALT) in Barrett's esophagus: prospective evaluation and association with gastric MALT, MALT lymphoma, and Helicobacter pylori.
    Weston AP; Cherian R; Horvat RT; Lawrinenko V; Dixon A; McGregor D
    Am J Gastroenterol; 1997 May; 92(5):800-4. PubMed ID: 9149188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicobacter pylori and gastric lymphoma: high seroprevalence of CagA in diffuse large B-cell lymphoma but not in low-grade lymphoma of mucosa-associated lymphoid tissue type.
    Delchier JC; Lamarque D; Levy M; Tkoub EM; Copie-Bergman C; Deforges L; Chaumette MT; Haioun C
    Am J Gastroenterol; 2001 Aug; 96(8):2324-8. PubMed ID: 11513169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma: a clinicopathologic and molecular study with reference to antibiotic treatment.
    Nakamura S; Matsumoto T; Ye H; Nakamura S; Suekane H; Matsumoto H; Yao T; Tsuneyoshi M; Du MQ; Iida M
    Cancer; 2006 Dec; 107(12):2770-8. PubMed ID: 17099876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Helicobacter pylori in gastric MALT-type lymphoma: differences between histologic and serologic diagnosis.
    Eck M; Greiner A; Schmausser B; Eck H; Kolve M; Fischbach W; Strecker P; Müller-Hermelink HK
    Mod Pathol; 1999 Dec; 12(12):1148-51. PubMed ID: 10619268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to Helicobacter pylori and CagA protein are associated with the response to antibacterial therapy in patients with H. pylori-positive API2-MALT1-negative gastric MALT lymphoma.
    Sumida T; Kitadai Y; Hiyama T; Shinagawa K; Tanaka M; Kodama M; Masuda H; Ito M; Tanaka S; Yoshihara M; Chayama K
    Cancer Sci; 2009 Jun; 100(6):1075-81. PubMed ID: 19385974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
    Chen LT; Lin JT; Tai JJ; Chen GH; Yeh HZ; Yang SS; Wang HP; Kuo SH; Sheu BS; Jan CM; Wang WM; Wang TE; Wu CW; Chen CL; Su IJ; Whang-Peng J; Cheng AL
    J Natl Cancer Inst; 2005 Sep; 97(18):1345-53. PubMed ID: 16174856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological and molecular analysis of B lymphocytes in low-grade MALT lymphoma of the stomach. Are there any useful markers for predicting outcome after Helicobacter pylori eradication?
    Matsushima Y; Kinoshita Y; Fukui H; Maekawa T; Yazumi S; Okada A; Nakase H; Kawanami C; Iwano M; Hashimoto K; Takeda Z; Okazaki K; Chiba T
    J Gastroenterol; 2002; 37(6):428-33. PubMed ID: 12108676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired T-cell regulation of B-cell growth in Helicobacter pylori--related gastric low-grade MALT lymphoma.
    D'Elios MM; Amedei A; Manghetti M; Costa F; Baldari CT; Quazi AS; Telford JL; Romagnani S; Del Prete G
    Gastroenterology; 1999 Nov; 117(5):1105-12. PubMed ID: 10535873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.